Miromatrix Medical

YTD

ALL

Why Robinhood?

You can watch MIRO and buy or sell other stocks, ETFs, and their options commission-free!

About MIRO

Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care.

CEO

Martine A. Rothblatt, PhD, MBA

CEOMartine A. Rothblatt, PhD, MBA

Employees

—

Employees—

Headquarters

Eden Prairie, Minnesota

HeadquartersEden Prairie, Minnesota

Founded

2009

Founded2009

Employees

—

Employees—

MIRO Key Statistics

Market cap

92.95M

Market cap92.95M

Price-Earnings ratio

-2.97

Price-Earnings ratio-2.97

Dividend yield

—

Dividend yield—

Average volume

80.13K

Average volume80.13K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$3.73

52 Week high$3.73

52 Week low

$0.9065

52 Week low$0.9065

People also own

Based on the portfolios of people who own MIRO. This list is generated using Robinhood data, and it’s not a recommendation.